Bendamustine
CAS No. 16506-27-7
Bendamustine( SDX105 )
Catalog No. M21612 CAS No. 16506-27-7
Bendamustine for?the treatment of Non-Hodgkin Lymphomas and Chronic Lymphocytic Leukemia.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
2MG | 41 | Get Quote |
|
5MG | 65 | Get Quote |
|
10MG | 110 | Get Quote |
|
25MG | 245 | Get Quote |
|
50MG | 385 | Get Quote |
|
100MG | 575 | Get Quote |
|
500MG | 1233 | Get Quote |
|
1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameBendamustine
-
NoteResearch use only, not for human use.
-
Brief DescriptionBendamustine for?the treatment of Non-Hodgkin Lymphomas and Chronic Lymphocytic Leukemia.
-
DescriptionBendamustine for?the treatment of Non-Hodgkin Lymphomas and Chronic Lymphocytic Leukemia.
-
In Vitro——
-
In Vivo——
-
SynonymsSDX105
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Areacancer
-
IndicationHodgkin's Disease Lymphoma
Chemical Information
-
CAS Number16506-27-7
-
Formula Weight358.26
-
Molecular FormulaC16H21Cl2N3O2
-
Purity>98% (HPLC)
-
SolubilityDMSO:72 mg/mL (200.97 mM)
-
SMILESCn1c(CCCC(O)=O)nc2cc(ccc12)N(CCCl)CCCl
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Patekar M B Milunovi V Jakobac K M et al. Bendamustine: an Old Drug in the New Era for Patients with Non-Hodgkin Lymphomas and Chronic Lymphocytic Leukemia[J]. Acta Clinica Croatica 2018 57(3):542-553.
molnova catalog
related products
-
2-Hydroxybenzylamine
2-Hydroxybenzylamine, a potent small molecule scavenger of IsoLGs, sequesters the reactive species as inert adducts.
-
Cyaonoside B
Cyaonoside B is isolated from S. simplex as a saponin and has a glucuronic acid attached to carbon C-3.
-
p-Hydroxy-5,6-dehydr...
p-Hydroxy-5,6-dehydrokawain is isolated from Kawain.